Tomografía Con Inteligencia Artificial
Dr. Marco V. Benavides Sánchez - 25 de junio de 2026.
https://medmultilingua.com/espanol/tomografia-con-inteligencia-artificial/
Medmultilingua.com
#AIinHealthcare #MedicalImaging #CTInnovation #SpectralCT #RadiologyAI #HealthTech #Medmultilingua
Dr. Marco V. Benavides Sánchez - 25 de junio de 2026.
https://medmultilingua.com/espanol/tomografia-con-inteligencia-artificial/
Medmultilingua.com
#AIinHealthcare #MedicalImaging #CTInnovation #SpectralCT #RadiologyAI #HealthTech #Medmultilingua
Neuralink, ELA y el futuro de comunicarse con el pensamiento
Dr. Marco V. Benavides Sánchez - 6 de julio de 2026.
https://medmultilingua.com/espanol/neuralink-ela-y-el-futuro-de-comunicarse-con-el-pensamiento/
Medmultilingua.com
#DigitalHealth #FutureOfMedicine #MedicalInnovation #Medmultilingua
Dr. Marco V. Benavides Sánchez - 6 de julio de 2026.
https://medmultilingua.com/espanol/neuralink-ela-y-el-futuro-de-comunicarse-con-el-pensamiento/
Medmultilingua.com
#DigitalHealth #FutureOfMedicine #MedicalInnovation #Medmultilingua
La revolución silenciosa: La FDA aprobó más dispositivos médicos con inteligencia artificial en 2025
Dr. Marco V. Benavides Sánchez - 17 de julio de 2026.
https://medmultilingua.com/espanol/la-revolucion-silenciosa-la-fda-aprobo-mas-dispositivos-medicos-con-inteligencia-artificial-en-2025/
Medmultilingua.com
#AIinHealthcare #MedicalAI #DigitalHealth #AIMedicalDevices #Medmultilingua
Dr. Marco V. Benavides Sánchez - 17 de julio de 2026.
https://medmultilingua.com/espanol/la-revolucion-silenciosa-la-fda-aprobo-mas-dispositivos-medicos-con-inteligencia-artificial-en-2025/
Medmultilingua.com
#AIinHealthcare #MedicalAI #DigitalHealth #AIMedicalDevices #Medmultilingua
Cuando las máquinas aprenden a cuidar la salud
Dr. Marco V. Benavides Sánchez - 3 de agosto, 2026.
Medmutilingua.com
#MedicalAI #AIMedicalDevices #MachineLearning #Wearables #Medmultilingua
Dr. Marco V. Benavides Sánchez - 3 de agosto, 2026.
Medmutilingua.com
#MedicalAI #AIMedicalDevices #MachineLearning #Wearables #Medmultilingua
IA y virus de laboratorio: lo que en verdad ocurrió y por qué el matiz importa
Dr. Marco V. Benavides Sánchez - Agosto 7, 2026.
https://medmultilingua.com/espanol/ia-y-virus-de-laboratorio-lo-que-en-verdad-ocurrio-y-por-que-el-matiz-importa/
Medmultilingua.com
#ArtificialIntelligence #Biosafety #PrecisionMedicine #NYTScience #Medmultilingua
Dr. Marco V. Benavides Sánchez - Agosto 7, 2026.
https://medmultilingua.com/espanol/ia-y-virus-de-laboratorio-lo-que-en-verdad-ocurrio-y-por-que-el-matiz-importa/
Medmultilingua.com
#ArtificialIntelligence #Biosafety #PrecisionMedicine #NYTScience #Medmultilingua
We just crossed a line in medicine that humanity has been walking toward for a hundred years.
For the first time, doctors can take a biopsy of your specific tumor, read its unique DNA mutations — the exact fingerprint no other cancer on earth shares — and build a custom mRNA blueprint written for one human being. Yours.
It doesn't poison the cancer. It teaches your own immune system what to hunt.
And this week, Phase 3 results confirmed it works.
Added to the best immunotherapy we already had, this individualized cancer vaccine has been dramatically cutting the odds that high-risk melanoma comes back. In the earlier data, the combination reduced the risk of recurrence or death by 49%, and the risk of the cancer spreading to distant organs by 62%, compared to the standard treatment alone. This week's Phase 3 readout confirmed the benefit holds. That is not a modest tweak. That is a different trajectory for a human life.
And melanoma is just the first door. The same approach is now in trials across lung, bladder, and kidney cancers — a whole program of them, racing forward.
Understand what this actually means, because it's bigger than one drug.
For all of history, we fought cancer with blunt weapons. Cut it out. Burn it with radiation. Flood the whole body with chemotherapy and hope the cancer dies before the patient suffers too much. We were swinging a hammer in the dark.
This is a blueprint. A weapon designed atom by atom for one person's disease, that turns their own body into the thing that finds and destroys it. We are watching medicine shift from managing cancer to hunting it.
I've spent my life as a physician, and I did not expect to see this so soon. We were told personalized cancer vaccines were a thirty-year dream. They are happening right now, in real patients, with real data, in our lifetime.
I don't say this lightly, and I say it as a doctor who knows exactly how rare these moments are: this is one of the most hopeful things to happen in the history of the field.
I woke up thinking of the words of the morning prayer — Modeh Ani — I thank You. Gratitude, the moment you open your eyes, for a soul returned and a day given. To be alive at the exact hour when human beings learned to teach the body to cure itself feels like standing inside that prayer.
We are not at the end of cancer. But we are, unmistakably, at the beginning of the end of its reign.
Afshine Emrani MD FACC
For the first time, doctors can take a biopsy of your specific tumor, read its unique DNA mutations — the exact fingerprint no other cancer on earth shares — and build a custom mRNA blueprint written for one human being. Yours.
It doesn't poison the cancer. It teaches your own immune system what to hunt.
And this week, Phase 3 results confirmed it works.
Added to the best immunotherapy we already had, this individualized cancer vaccine has been dramatically cutting the odds that high-risk melanoma comes back. In the earlier data, the combination reduced the risk of recurrence or death by 49%, and the risk of the cancer spreading to distant organs by 62%, compared to the standard treatment alone. This week's Phase 3 readout confirmed the benefit holds. That is not a modest tweak. That is a different trajectory for a human life.
And melanoma is just the first door. The same approach is now in trials across lung, bladder, and kidney cancers — a whole program of them, racing forward.
Understand what this actually means, because it's bigger than one drug.
For all of history, we fought cancer with blunt weapons. Cut it out. Burn it with radiation. Flood the whole body with chemotherapy and hope the cancer dies before the patient suffers too much. We were swinging a hammer in the dark.
This is a blueprint. A weapon designed atom by atom for one person's disease, that turns their own body into the thing that finds and destroys it. We are watching medicine shift from managing cancer to hunting it.
I've spent my life as a physician, and I did not expect to see this so soon. We were told personalized cancer vaccines were a thirty-year dream. They are happening right now, in real patients, with real data, in our lifetime.
I don't say this lightly, and I say it as a doctor who knows exactly how rare these moments are: this is one of the most hopeful things to happen in the history of the field.
I woke up thinking of the words of the morning prayer — Modeh Ani — I thank You. Gratitude, the moment you open your eyes, for a soul returned and a day given. To be alive at the exact hour when human beings learned to teach the body to cure itself feels like standing inside that prayer.
We are not at the end of cancer. But we are, unmistakably, at the beginning of the end of its reign.
Afshine Emrani MD FACC
Vacunas hechas a la medida: el avance que podría transformar el tratamiento del melanoma
Dr. Marco V. Benavides Sánchez - Agosto 20, 2026.
https://medmultilingua.com/espanol/vacunas-hechas-a-la-medida-el-avance-que-podria-transformar-el-tratamiento-del-melanoma/
Medmultilingua.com
• #mRNATherapeutics
• #CancerVaccine
• #ImmunoOncology
• #Moderna
• #Merck
• #KEYTRUDA
• #ClinicalTrials
• #Phase3Results
• #Medmultilingua
Dr. Marco V. Benavides Sánchez - Agosto 20, 2026.
https://medmultilingua.com/espanol/vacunas-hechas-a-la-medida-el-avance-que-podria-transformar-el-tratamiento-del-melanoma/
Medmultilingua.com
• #mRNATherapeutics
• #CancerVaccine
• #ImmunoOncology
• #Moderna
• #Merck
• #KEYTRUDA
• #ClinicalTrials
• #Phase3Results
• #Medmultilingua